Wednesday, March 24, 2021

AstraZeneca COVID vaccine 76% effective in new US trial analysis

New analysis from vaccine developer uses latest data and follows rebuke from US health officials.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)